SCHEMBL2592755

SCHEMBL2592755

CC(C)(C)N1CC(C(=O)Nc2cc(Oc3cc(F)c(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccn2)C1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 16/20 0.81
MET P08581 9/20 0.81
NTRK1 P04629 3/20 0.81
TEK Q02763 2/20 0.81
NTRK2 Q16620 2/20 0.81
NTRK3 Q16288 1/20 0.81
RIPK2 O43353 2/20 0.52
RIPK3 Q9Y572 2/20 0.52
MST1R Q04912 2/20 0.52
EPHB6 O15197 1/20 0.52
ABL1 P00519 1/20 0.52
LCK P06239 1/20 0.52
LYN P07948 1/20 0.52
RET P07949 1/20 0.52
HCK P08631 1/20 0.52
PDGFRB P09619 1/20 0.52
BCR P11274 1/20 0.52
EPHA2 P29317 1/20 0.52
EPHB2 P29323 1/20 0.52
FLT3 P36888 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL138653 0.90 KDR (0.77) KDRMETNTRK1TEKNTRK2
Altiratinib SCHEMBL30337737 0.90 KDR (1.00) KDRMETNTRK1TEKNTRK2
Altiratinib SCHEMBL30128694 0.90 KDR (1.00) KDRMETNTRK1TEKNTRK2
Altiratinib SCHEMBL139906 0.90 KDR (1.00) KDRMETNTRK1TEKNTRK2
Altiratinib SCHEMBL29358783 0.90 KDR (1.00) KDRMETNTRK1TEKNTRK2
SCHEMBL142079 0.88 KDR (0.93) KDRMETNTRK1TEKNTRK2
SCHEMBL145837 0.86 KDR (0.87) KDRMETNTRK1TEKNTRK2
SCHEMBL143823 0.86 MET (0.78) KDRMETNTRK1TEKNTRK2
SCHEMBL142812 0.86 MET (0.77) KDRMETNTRK1TEKNTRK2
SCHEMBL138396 0.85 MET (0.82) KDRMETNTRK1TEKNTRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2563362-A1 CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITES Deciphera Pharmaceuticals, LLC (US) 2013-03-06 EP disclosed
WO-2011137342-A1 CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITES DECIPHERA PHARMACEUTICALS, LLC (US) 2011-11-03 WO disclosed